Mechanism of the histamine H3 receptor-mediated increase in exploratory locomotor activity and anxiety-like behaviours in mice

Neuropharmacology

Volumn 81, Issue , 2014, Pages 188-194

  Mohsen, Attayeb ^a   Yoshikawa, Takeo ^a   Miura, Yamato ^a   Nakamura, Tadaho ^a   Naganuma, Fumito ^a   Shibuya, Katsuhiko ^a   Iida, Tomomitsu ^a   Harada, Ryuichi ^a   Okamura, Nobuyuki ^a   Watanabe, Takehiko ^a   Yanai, Kazuhiko ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anxiety like behaviours; Brain histamine; Locomotor activity

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ALPHA FLUOROMETHYL HISTIDINE; DIPHENHYDRAMINE; DOPAMINE; ENZYME INHIBITOR; HISTAMINE; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTIDINE DECARBOXYLASE; HOMOVANILLIC ACID; JNJ 10181457; N METHYLHISTAMINE; NORADRENALIN; SEROTONIN; UNCLASSIFIED DRUG; ZOLANTIDINE; 4-(3-(4-PIPERIDIN-1-YLBUT-1-YNYL)BENZYL)MORPHOLINE; ALPHA-FLUOROMETHYLHISTIDINE; ANTIHISTAMINIC AGENT; BIOGENIC AMINE; HISTAMINE DERIVATIVE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTIDINE DERIVATIVE; MORPHOLINE DERIVATIVE; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; ELEVATED ZERO MAZE TEST; EXPLORATORY BEHAVIOR; HISTAMINE RELEASE; IN VIVO STUDY; KNOCKOUT MOUSE; LOCOMOTION; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RECEPTOR BLOCKING; ANIMAL; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; MAZE TEST; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TOXICITY;

ANIMALS; ANXIETY; BIOGENIC MONOAMINES; BRAIN; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EXPLORATORY BEHAVIOR; HISTAMINE; HISTAMINE ANTAGONISTS; MALE; MAZE LEARNING; METHYLHISTAMINES; METHYLHISTIDINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOLINES; PIPERIDINES; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; RECEPTORS, HISTAMINE H3;

EID: 84895520976     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.02.003     Document Type: Article

References (62)

1. 2 histamine antagonists on exploratory behavior in male rats Physiol. Behav. 37 1985 39 45
2. J.M. Arrang, M. Garbarg, J.C. Lancelot, J.M. Lecomte, H. Pollard, M. Robba, W. Schunack, and J.C. Schwartz Highly potent and selective ligands for histamine H3-receptors Nature 327 1987 117 123
3. J.M. Arrang, M. Garbarg, and J.C. Schwartz Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor Nature 302 1983 832 837
4. A.J. Barbier, C. Berridge, C. Dugovic, A.D. Laposky, S.J. Wilson, J. Boggs, L. Aluisio, B. Lord, C. Mazur, C.M. Pudiak, X. Langlois, W. Xiao, R. Apodaca, N.I. Carruthers, and T.W. Lovenberg Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist Br. J. Pharmacol. 143 2004 649 661
5. P. Bonaventure, M. Letavic, C. Dugovic, S. Wilson, L. Aluisio, C. Pudiak, B. Lord, C. Mazur, F. Kamme, S. Nishino, N. Carruthers, and T. Lovenberg Histamine H3 receptor antagonists: from target identification to drug leads Biochem. Pharmacol. 73 2007 1084 1096
6. G. Bongers, R. Leurs, J. Robertson, and J. Raber Role of H3-receptor-mediated signaling in anxiety and cognition in wild-type and Apoe-/-mice Neuropsychopharmacology 29 2003 441 449
7. R.E. Brown, D.R. Stevens, and H.L. Haas The physiology of brain histamine Prog. Neurobiol. 2001 637 672
8. C.R.C. Calcutt, C.R.C. Ganellin, R.R. Griffiths, B.K.B. Leigh, J.P.J. Maguire, R.C.R. Mitchell, M.E.M. Mylek, M.E.M. Parsons, I.R.I. Smith, and R.C.R. Young Zolantidine (SK & amp; F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist Br. J. Pharmacol. 93 1987 69 78
9. J.J. Clapham, and G.J.G. Kilpatrick Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse Eur. J. Pharmacol. 259 1994 107 114
10. 4 receptor is functionally expressed on neurons in the mammalian CNS Br. J. Pharmacol. 157 2009 55 63
11. M.N. Cook, M. Crounse, and L. Flaherty Anxiety in the elevated zero-maze is augmented in mice after repeated daily exposure Behav. Genet. 32 2002 113 118
12. H. Dai, K. Kaneko, H. Kato, S. Fujii, Y. Jing, A. Xu, E. Sakurai, M. Kato, N. Okamura, A. Kuramasu, and K. Yanai Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors Neurosci. Res. 57 2007 306 313
13. 4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability Br. J. Pharmacol. 167 2012 905 916
14. C.A. Dvorak, R. Apodaca, W. Xiao, J.A. Jablonowski, P. Bonaventure, C. Dugovic, J. Shelton, B. Lord, K. Miller, L.K. Dvorak, T.W. Lovenberg, and N.I. Carruthers Diamine-based human histamine H3 receptor antagonists: (4-Aminobutyn-1-yl) benzylamines Eur. J. Med. Chem. 44 2009 4098 4106
15. S.E. File, L.E. Gonzalez, and N. Andrews Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic1 receptors Behav. Neurosci. 112 1998 352 359
16. R. Galici, J.D. Boggs, L. Aluisio, I.C. Fraser, P. Bonaventure, B. Lord, and T.W. Lovenberg JNJ-10181457, a selective non-imidazole histamine H3 receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition Neuropharmacology 56 2009 1131 1137
17. M. Garbarg, G. Barbin, E. Rodergas, and J.C. Schwartz Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies J. Neurochem. 35 1980 1045 1052
18. E. García-Martín, P. Ayuso, C. Martínez, M. Blanca, and J.A. Agúndez Histamine pharmacogenomics Pharmacogenomics 10 2009 867 883
19. 4 receptors: structure-activity relationships of histamine derivatives Br. J. Pharmacol. 147 2006 744 754
20. P. Ghi, G. Di Carlo, and L. Molinengo Effects of thioperamide on locomotor activity and on memory processes Prog. Neuro-Psychopharmacol. Bio. Psychiatr. 22 1998 387 395
21. H. Haas, and P. Panula The role of histamine and the tuberomamillary nucleus in the nervous system Nat. Rev. Neurosci. 4 2003 121 130
22. H.L. Haas, O.A. Sergeeva, and O. Selbach Histamine in the nervous system Physiol. Rev. 88 2008 1183 1241
23. Y.C. He, G.Y. Wu, D. Li, B. Tang, B. Li, Y. Ding, J.N. Zhu, and J.J. Wang Histamine promotes rat motor performances by activation of H2 receptors in the cerebellar fastigial nucleus Behav. Brain Res. 228 2012 44 52
24. R.W. Hew, C.R. Hodgkinson, and S.J. Hill Characterization of histamine H3-receptors in guinea-pig ileum with H3-selective ligands Br. J. Pharmacol. 101 1990 621 624
25. M. Imaizumi, and K. Onodera The behavioral and biochemical effects of thioperamide, a histamine H3-receptor antagonist, in a light/dark test measuring anxiety in mice Life Sci. 53 1993 1675 1683
26. C. Inocente, I. Fau Arnulf, H. Bastuji, A. Thibault-Stoll, A. Raoux, R. Reimao, J.-S. Lin, and P. Franco Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness Clin. Neuropharmacol. 35 2012 55 60
27. I. Inoue, K. Yanai, D. Kitamura, I. Taniuchi, T. Kobayashi, K. Niimura, T. Watanabe, and T. Watanabe Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors Proc. Natl. Acad. Sci. U. S. A. 93 1996 13316 13320
28. F. Jia, M. Kato, H. Dai, A. Xu, T. Okuda, E. Sakurai, N. Okamura, T.W. Lovenberg, A. Barbier, N.I. Carruthers, K. Iinuma, and K. Yanai Effects of histamine H3 antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice Neuropharmacology 50 2006 404 411
29. J. Kehr, and T. Yoshitake Determination of histamine in microdialysis samples from the rodent brain by column liquid chromatography Microdialysis Techniques in Neuroscience vol. 75 2012 299 320
30. C. Kilkenny, W.J. Browne, I.C. Cuthill, M. Emerson, and D.G. Altman Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research PLoS Biol. 8 2010 e1000412
31. T. Kobayashi, S. Tonai, Y. Ishihara, R. Koga, S. Okabe, and T. Watanabe Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice J. Clin. Invest. 105 2000 1741 1749
32. V.A. Komater, M.J. Buckley, K.E. Browman, J.B. Pan, A.A. Hancock, M.W. Decker, and G.B. Fox Effects of histamine H3 receptor antagonists in two models of spatial learning Behav. Brain Res. 159 2005 295 300
33. H. Komori, Y. Nitta, H. Ueno, and Y. Higuchi Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase J. Biol. Chem. 287 2012 29175 29183
34. D.A. McCormick, and A. Williamson Modulation of neuronal firing mode in cat and guinea pig LGNd by histamine: possible cellular mechanisms of histaminergic control of arousal J. Neurosci. 11 1991 3188 3199
35. J.C. McGrath, G.B. Drummond, E.M. McLachlan, C. Kilkenny, and C.L. Wainwright Guidelines for reporting experiments involving animals: the ARRIVE guidelines Br. J. Pharmacol. 160 2010 1573 1576
36. K. Meskanen, H. Ekelund, J. Laitinen, P.J. Neuvonen, J. Haukka, P. Panula, and J. Ekelund A randomized clinical trial of histamine 2 receptor antagonism in treatment-resistant schizophrenia Eur. Neuropsychopharmacol. 23 2013 S461
37. S. Miyazaki, M. Imaizumi, and K. Onodera Effects of thioperamide, a histamine H3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in mice Life Sci. 57 1994 2137 2144
38. T. Mochizuki, A. Yamatodani, K. Okakura, M. Takemura, N. Inagaki, and H. Wada In vivo release of neuronal histamine in the hypothalamus of rats measured by microdialysis Naunyn Schmiede-Bergs Arch. Pharmacol. 343 1991 190 195
39. M. Motawaj, A. Burban, E. FauDavenas, and J.M. Arrang Activation of brain histaminergic neurotransmission: a mechanism for cognitive effects of memantine in Alzheimer's disease J. Pharmacol. Exp. Ther. 336 2011 479 487
40. R.F. Orzechowski, D.S. Currie, and C.A. Valancius Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models Eur. J. Pharmacol. 506 2005 257 264
41. P. Panula, and S. Nuutinen The histaminergic network in the brain: basic organization and role in disease Nat. Rev. Neurosci. 14 2013 1 16
42. P. Panula, H.Y. Yang, and E. Costa Histamine-containing neurons in the rat hypothalamus Proc. Natl. Acad. Sci. U. S. A. 81 1984 2572 2576
43. M.B. Passani, P. Giannoni, C. Bucherelli, E. Baldi, and P. Blandina Histamine in the brain: beyond sleep and memory Biochem. Pharmacol. 73 2007 1113 1122
44. K. Saitou, Y. Kaneko, Y. Fau Sugimoto, Z. Chen, and C. Kamei Slow wave sleep-inducing effects of first generation H1-antagonists Biol. Pharm. Bull. 22 1999 1079 1082
45. N. Sakai, K. Onodera, K. Maeyama, K. Yanai, and T. Watanabe Effects of thioperamide, a histamine H3 receptor antagonist, on locomotor activity and brain histamine content in mast cell-deficient W/Wv mice Life Sci. 48 1991 2397 2404
46. N. Sakai, E. Sakurai, E. Sakurai, K. Yanai, Y. Mirua, and T. Watanabe Depletion of brain histamine induced by alpha-fluoromethylhistidine enhances radial maze performance in rats with modulation of brain amino acid levels Life Sci. 62 1997 989 994
47. T. Sallmen, A.L. Beckman, T.L. Stanton, K.S. Eriksson, J. Thrhanen, L. Tumisto, and P. Panula Major changes in the brain histamine system of the ground squirrel citellus lateralis during hibernation J. Neurosci. 19 1999 1824 1835
48. J.C. Schwartz The histamine H3 receptor: from discovery to clinical trials with pitolisant Br. J. Pharmacol. 163 2011 713 721
49. O. Selbach, R.E. Brown, and H.L. Haas Long-term increase of hippocampal excitability by histamine and cyclic AMP Neuropharmacology 36 1997 1539 1548
50. K. Shibuya, Y. Funaki, K. Hiraoka, T. Yoshikawa, F. Naganuma, M. Miyake, S. Watanuki, H. Sato, M. Tashiro, and K. Yanai [11C]Doxepin binding to histamine H1 receptors in living human brain: reproducibility during attentive waking and circadian rhythm Front. Syst. Neurosci. 6 2012 45
51. M.I. Strakhova, A.L. Nikkel, A.M. Manelli, G.C. Hsieh, T.A. Esbenshade, J.D. Brioni, and R.S. Bitner Localization of histamine H4 receptors in the central nervous system of human and rat Brain Res. 1250 2009 41 48
52. 3 receptors Mol. Pharmacol. 62 2002 389 397
53. T. Watanabe, Y. Taguchi, H. Hayashi, J. Tanaka, S. Shiosaka, M. Tohyama, H. Kubota, Y. Terano, and H. Wada Evidence for the presence of a histaminergic neuron system in the rat brain: an immunohistochemical analysis Neurosci. Lett. 39 1983 249 254
54. T. Watanabe, Y. Taguchi, S. Shiosaka, J. Tanaka, H. Kubota, Y. Terano, M. Tohyama, and H. Wada Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker Brain Res. 295 1984 1 13
55. T. Watanabe, A. Yamatodani, K. Maeyama, and H. Wada Pharmacology of alpha-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase Trends Pharmacol. Sci. 11 1990 363 367
56. T. Watanabe, and K. Yanai Studies on functional roles of the histaminergic neuron system by using pharmacological agents, knockout mice and positron emission tomography Tohoku J. Exp. Med. 195 2001 197 217
57. R.H. Weisler, G.J. Pandina, E.J. Daly, K. Cooper, C. Gassmann-Mayer Investigators, A.S Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder CNS Drugs 26 2012 421 434
58. A. Xu, E. Sakurai, A. Kuramasu, J. Zhang, J. Li, N. Okamura, D. Zhang, T. Yoshikawa, T. Watanabe, and K. Yanai Roles of hypothalamic subgroup histamine and orexin neurons on behavioral responses to sleep deprivation induced by the treadmill method in adolescent rats J. Pharm. Sci. 114 2010 444 453
59. K. Yanai, L.Z. Son, M. Endou, E. Sakurai, O. Nakagawasai, T. Tadano, K. Kisara, I. Inoue, T. Watanabe, and T. Watanabe Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors Neuroscience 87 1998 479 487
60. K. Yanai, D. Zhang, M. Tashiro, T. Yoshikawa, F. Naganuma, R. Harada, T. Nakamura, K. Shibuya, and N. Okamura Positron emission tomography evaluation of sedative properties of antihistamines Expert Opin. Drug. Saf. 10 2011 613 622
61. T. Yoshikawa, F. Naganuma, T. Iida, T. Nakamura, R. Harada, A.S. Mohsen, A. Kasajima, H. Sasano, and K. Yanai Molecular mechanism of histamine clearance by primary human astrocytes Glia 61 2013 905 916
62. D. Zhang, M. Tashiro, K. Shibuya, N. Okamura, Y. Funaki, T. Yoshikawa, M. Kato, and K. Yanai Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography J. Clin. Psychopharmacol. 30 2010 694 701